MEDSIR, Featured Company at the Shanghai International Medical Oncology Symposium (7th SIMOS) MEDSIR, leading company in advancing independent clinical research in oncology, participated in the 7th SIMOS at Shanghai, China.

MEDSIR, Featured Company at the Shanghai International Medical Oncology Symposium (7th SIMOS) MEDSIR, a leader in independent clinical research in oncology, strengthens its commitment to international collaboration and the exchange of scientific knowledge.Dr. Antonio Llombart-Cussac, Senior...

MEDSIR，第七届上海国际肿瘤内科学论坛 (SIMOS) 特邀企业 MEDSIR，作为肿瘤学独立临床研究的领军企业，进一步强化了其对于推动国际合作及科学知识交流的承诺。MEDSIR高级科学主管Antonio Llombart-Cussac博士发表了题为“HR+/HER2-乳腺癌的临床实践与未来管理” (Clinical Practice and Future Management of HR+/HER2- Breast Cancer)...

出席上海國際腫瘤內科學論壇（第 7 屆 SIMOS）的重點公司 - MEDSIR 腫瘤學獨立臨床研究的領先機構 MEDSIR 加強與國際間合作及科學知識交流的承諾。MEDSIR 高級科學主管 Antonio Llombart-Cussac 博士發表題為「HR+/HER2- 型乳癌的臨床實踐及未來管理」 （"Clinical Practice and Future Management of HR+/HER2- Breast...